Research
Rescue of glutaric aciduria type I by GalNAc-conjugated siRNA against aminoadipate semialdehyde synthase
Science · By Yunhan Ma, Maiya Fujiwara, Natasha Murugan, Haoyue Zhang, Sabrina Belozerova, James Beasley, Cheryl K. Peck, Timothy C. Wood, Ashlee R. Stiles, Sarah Young, Areeg El-Gharbawy, Mercedes Barzi, Beatrice Bissig-Choisat, Leila Noetzli & Karl-Dimiter Bissig ·
The Brief
- A study in Science Translational Medicine reports that a GalNAc-conjugated siRNA targeting aminoadipate semialdehyde synthase rescued glutaric aciduria type I in models.
- The paper appeared in Volume 18, Issue 876 of Science Translational Medicine, November 2026.
Why it matters
The study reports rescue of glutaric aciduria type I in model systems using siRNA silencing of aminoadipate semialdehyde synthase, pointing to a possible therapeutic approach for the condition.
Who’s affected
- researchers in metabolic disease and gene-silencing therapeutics
- clinicians and families affected by glutaric aciduria type I
- #glutaric aciduria type i
- #sirna
- #gene silencing
- #metabolic disease
- #rare disease
Science Translational Medicine, Volume 18, Issue 876 , November 2026.